Pacer BioThreat Strategy ETF (VIRS) Institutional Ownership $40.02 0.00 (0.00%) As of 10/10/2024 Add Compare Share Share Ownership Stock AnalysisDividendHoldingsOwnershipBuy This Stock Institutional Ownership Changes (13F Filings) for Pacer BioThreat Strategy ETF (BATS:VIRS)Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$11.27K Get VIRS Insider Trade Alerts Want to know when executives and insiders are buying or selling Pacer BioThreat Strategy ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VIRS Institutional Buying and Selling by Quarter Pacer BioThreat Strategy ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/30/2024 International Assets Investment Management LLC18,355$667K0.0%-1.7%18.355% 4/11/2024 International Assets Investment Management LLC18,665$671K0.0%-1.7%14.358% 1/25/2024 International Assets Investment Management LLC18,989$614K0.0%N/A14.607% 1/24/2024 International Assets Investment Management LLC613,651$18.99M0.0%N/A472.039% 1/30/2023 International Assets Investment Management LLC368,307$4.89M0.4%N/A0.000% 1/24/2023 International Assets Investment Management LLC368,307$4.89M1.0%N/A0.000% (Data available from 1/1/2016 forward) VIRS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VIRS shares? During the previous two years, the following institutional investors and hedge funds held shares of Pacer BioThreat Strategy ETF shares: International Assets Investment Management LLC ($667K).Learn more on VIRS's institutional investors. Which institutional investors have been buying Pacer BioThreat Strategy ETF stock? The following institutional investors have purchased Pacer BioThreat Strategy ETF stock in the last 24 months: International Assets Investment Management LLC ($632.64K). How much institutional buying is happening at Pacer BioThreat Strategy ETF? Institutional investors have bought a total of 632,640 shares in the last 24 months. This purchase volume represents approximately $20.44M in transactions. Which Pacer BioThreat Strategy ETF major shareholders have been selling company stock? The following institutional investors have sold Pacer BioThreat Strategy ETF stock in the last 24 months: International Assets Investment Management LLC ($634.00). How much institutional selling is happening at Pacer BioThreat Strategy ETF? Institutional investors have sold a total of 634 shares in the last 24 months. This volume of shares sold represents approximately $23.00K in transactions. Related Companies ProShares Nanotechnology ETF Institutional Ownership Xtrackers US Green Infrastructure Select Equity ETF Institutional Ownership NYLI Clean Oceans ETF Institutional Ownership Bitwise Web3 ETF Institutional Ownership Global X Solar ETF Institutional Ownership Roundhill Cannabis ETF Institutional Ownership Grizzle Growth ETF Institutional Ownership AdvisorShares Restaurant ETF Institutional Ownership iShares Neuroscience and Healthcare ETF Institutional Ownership Harbor Human Capital Factor Unconstrained ETF Institutional Ownership This page (BATS:VIRS) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacer BioThreat Strategy ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacer BioThreat Strategy ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VIRS Stock Free VIRS Stock Alerts